Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
April 17th, 2009
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, reported financial results for the fourth quarter and year ended December 31, 2008. "Catalyst made significant progress in 2008," said Patrick J. McEnany, Chief Executive Officer of Catalyst Pharmaceutical Partners. "During the year, we initiated two U.S. multi-center, Phase II, double-blind, placebo-controlled trials evaluating CPP-109 as a potential treatment for cocaine and methamphetamine addiction. In September we executed a successful equity financing for $4.5 million just...
Source: Health Business Week (2009-04-17)
|
